XML 47 R30.htm IDEA: XBRL DOCUMENT
v3.19.1

Financial Instruments and Financial Risk Management (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2018
Financial Instruments and Financial Risk Management [Abstract] |
Schedule of analyzes non-derivative financial liabilities |
|  | Less than one year |  |  | Between one to two years |
|  | U.S. dollars in thousands |
December 31, 2018: |  |  |
IIA liability |  |  | 49 |  |  |  | 82 |
Trade payables and other payables |  |  | 1,054 |  |  |  | - |
|  |  | 1,103 |  |  |  | 82 |
December 31, 2017: |  |  |  |  |  |  |  |
IIA liability |  |  | 92 |  |  |  | - |
Trade payables and other payables |  |  | 1,055 |  |  |  | - |
|  |  | 1,147 |  |  |  | - |
Schedule of changes in level 3 instruments |
|  | Anti-dilution feature |  |  | Derivative financial instruments |  |  | Total |
|  | U.S. dollar in thousands |
Balance as of January 1, 2018 |  |  | 692 |  |  |  | 61 |  |  |  | 753 |
Initial recognition |  |  | 497 |  |  |  | 2,678 |  |  |  | 3,175 |
Finance expenses |  |  | 598 |  |  |  | 1,641 |  |  |  | 2,239 |
Classification to equity of Series B warrants |  |  | - |  |  |  | (3,479 | ) |  |  | (3,479 | )
Classification to level 1 (see Note 13(e)) |  |  | - |  |  |  | (901 | ) |  |  | (901 | )
Exercise of anti-dilution feature |  |  | (1,787 | ) |  |  | - |  |  |  | (1,787 | )
Balance as of December 31, 2018 |  |  | - |  |  |  | - |  |  |  | - |
Total unrealized losses for the period included in profit or loss for liabilities held at December 31, 2018 |  |  | 598 |  |  |  | 1,641 |  |  |  | 2,239 |
|  | Anti-dilution feature |  |  | Derivative financial instruments |  |  | Total |
|  | U.S. dollar in thousands |
Balance as of January 1, 2017 |  |  | 94 |  |  |  | - |  |  |  | 94 |
Initial recognition |  |  | 315 |  |  |  | 1,958 |  |  |  | 2,273 |
Finance expenses (income) |  |  | 283 |  |  |  | (1,897 | ) |  |  | (1,614 | )
Balance as of December 31, 2017 |  |  | 692 |  |  |  | 61 |  |  |  | 753 |
Total unrealized losses (gains) for the period included in profit or loss for liabilities held at December 31, 2017 |  |  | 283 |  |  |  | (1,897 | ) |  |  | (1,614 | )
|  | Anti-dilution feature |  |  | Options to group of investors |  |  | Bridge loan |  |  | Financing of issuance expenses |  |  | Total |
|  | U.S. dollar in thousands |
Balance as of January 1, 2016 |  | - |  |  | - |  |  | * |  |  | * |  |  | * |
Initial recognition |  |  | 106 |  |  |  | 193 |  |  |  | - |  |  |  | - |  |  |  | 299 |
Finance expenses (income) |  |  | (12 | ) |  |  | - |  |  |  | 800 | ** |  |  | 256 | ** |  |  | 1,044 |
Settlement/cancellation |  |  | - |  |  |  | (193 | ) |  |  | (800 | ) |  |  | (256 | ) |  |  | (1,249 | )
Balance as of December 31, 2016 |  |  | 94 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 94 |
Total unrealized gains for the period included in profit or loss for liabilities held at December 31, 2016 |  |  | (12 | ) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (12 | )
| * | Represents an amount of less than $ 1 thousands.
| ** | Recognition of deferred initial loss at an amount equal to the cash amount paid by the Company at the time of completion the Merger Transaction.
Schedule of financial instruments |
|  | Financial assets at amortized cost |
December 31, 2018 |  | U.S. dollars in thousands |
Assets: |  |  |  |
Cash and cash equivalents |  |  | 3,717 |
Trade receivable and other receivables (excluding prepaid expenses) |  |  | 910 |
Restricted deposits |  |  | 104 |
|  |  | 4,731 |
|  | Loans and receivables |
December 31, 2017 |  | U.S. dollars in thousands |
Assets: |  |  |  |
Cash and cash equivalents |  |  | 3,514 |
Trade receivable and other receivables (excluding prepaid expenses) |  |  | 740 |
Restricted deposits |  |  | 93 |
|  |  | 4,347 |
|  | Liabilities at fair value through profit or loss |  |  | Financial liabilities at amortized cost |  |  | Total |
December 31, 2018 |  | U.S. dollars in thousands |
Liabilities: |  |  |  |  |  |  |  |  |
Trade payables and other payables |  |  | - |  |  |  | 1,054 |  |  |  | 1,054 |
IIA liability |  |  | - |  |  |  | 131 |  |  |  | 131 |
Derivative financial instruments |  |  | 729 |  |  |  | - |  |  |  | 729 |
|  |  | 729 |  |  |  | 1,185 |  |  |  | 1,914 |
December 31, 2017 |  |  |  |  |  |  |  |  |  |  |  |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Trade payables and other payables |  |  | - |  |  |  | 1,055 |  |  |  | 1,055 |
IIA liability |  |  | - |  |  |  | 92 |  |  |  | 92 |
Derivative financial instruments |  |  | 237 |  |  |  | - |  |  |  | 237 |
Liability in respect of anti-dilution feature |  |  | 692 |  |  |  | - |  |  |  | 692 |
|  |  | 929 |  |  |  | 1,147 |  |  |  | 2,076 |

X
- References No definition available. + Details
Name: | SFET_FinancialInstrumentsAndFinancialRiskManagementAbstract
Namespace Prefix: | SFET_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the fair value measurement of liabilities. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2018-01-01 -Paragraph 93 -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=13&date=2018-03-01&anchor=para_93&doctype=Standard -URIDate 2018-03-16 + Details
Name: | ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the fair value of financial instruments. [Refer: Financial instruments, class [member]; At fair value [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2018-01-01 -Paragraph 10 -Subparagraph e -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=1&date=2018-03-01&anchor=para_10_e&doctype=Standard -URIDate 2018-03-16 + Details
Name: | ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of a maturity analysis for non-derivative financial liabilities (including issued financial guarantee contracts) that shows the remaining contractual maturities. [Refer: Derivative financial liabilities] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2018-01-01 -Paragraph 39 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=7&date=2018-03-01&anchor=para_39_a&doctype=Standard -URIDate 2018-03-16 + Details
Name: | ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration